TITLE

Platelet Aggregation and Exogenous Factors From Animal Sources

AUTHOR(S)
Kini, R. Manjunatha
PUB. DATE
December 2004
SOURCE
Current Drug Targets - Cardiovascular & Haematological Disorders;Dec2004, Vol. 4 Issue 4, p301
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Platelet aggregation plays a crucial role in thrombosis. This review describes exogenous factors isolated from various animal sources, including venoms and the salivary glands that interfere in platelet aggregation. Some of these factors induce platelet aggregation or agglutination, whereas others inhibit platelet aggregation. These proteins range from small molecular weight peptides to large proteins. Some of these proteins exhibit various enzymatic activities, while others are nonenzymatic. These exogenous factors affect platelet aggregation by various mechanisms and thus they have been classified based on their mechanism of action. Many of these proteins have evolved through both convergent and divergent evolution. For example, platelet aggregation inhibitors, which interfere in the interactions between fibrinogen and its receptor, the glycoprotein IIb / IIIa complex, show extreme structural diversity but they share the common functional site of Arg-Gly-Asp (RGD) tripeptide segment. On the other hand, C-type lectin related proteins exhibit diverse biological effects by interacting with different proteins, but share common structural scaffold. Thus the mechanistic and structure-function studies of these exogenous proteins have contributed significantly to the understanding of molecular mechanisms of platelet aggregation and to the development of potent antiplatelet agents, respectively. A number of new exogenous factors have been identified recently and the search is still on for novel factors that interfere with platelet aggregation. Further studies in this area will help in the development of novel strategies for treating cardiovascular and hematological disorders.
ACCESSION #
15286390

 

Related Articles

  • Evaluation of Whole-Blood Lumiaggregation. Podczasy, John J.; Lee, James; Vucenik, Ivana // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p190 

    An evaluation of whole-blood Unappreciation was conducted in a normal population. Platelet aggregation and adenosine triphosphate (ATP) secretion were monitored in a three-phase study that analyzed sample dilution, agonist dose response, and method comparison. In the first phase, the...

  • Global Anticoagulant Effects of a Synthetic Anti-Factor Xa Inhibitor (DX-9065a): Implications for Interventional Use. Tobu, Mahmut; Iqbal, Omer; Qing Ma; Schultz, Christopher; Jeske, Walter; Hoppensteadt, Debra; Lewis, Bruce; Fareed, Daniel; Fareed, Jawed // Clinical & Applied Thrombosis/Hemostasis;Jan2003, Vol. 9 Issue 1, p1 

    Heparin has been conventionally used as an anticoagulant for medical and surgical indications. Because factor Xa is an essential component of the prothrombinase complex and leads to the generation of thrombin, its inhibition has become a focus of newer antithrombotic drug development. The in...

  • Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry. Kageyama, Kyoko; Mizobe, Toshiki; Nozuchi, Shinji; Hiramatsu, Noriko; Nakajima, Yasufumi; Aoki, Hiroshi // Journal of Anesthesia;2004, Vol. 18 Issue 2, p107 

    Purpose Methods. Washed human platelets were preincubated with toborinone or olprinone, then exposed to 0.015 U�ml-1 of thrombin. Aggregation curves were measured using an aggregometer. Effects of toborinone or olprinone on changes in intracellular calcium concentration ([Ca2+]i) were...

  • Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides. Hollenberg, Morley D; Saifeddine, Mahmoud // Canadian Journal of Physiology & Pharmacology;May2001, Vol. 79 Issue 5, p439 

    We studied the actions of receptor-activating peptide analogues (PAR4APs), modeled on the proteolytically-revealed tethered ligand sequence of murine proteinase-activated receptor-4 (PAR4), in a rat platelet aggregation assay. The PAR4APs GYPGKF-NH[sub 2] (GY-NH[sub 2] ) and AYPGKF-NH[sub 2]...

  • Ten Years' Experience with the "Sticky Platelet Syndrome" Mammen, Eberhard F. // Clinical & Applied Thrombosis/Hemostasis;Winter1995, Vol. 1 Issue 1, p66 

    We describe a 10-year experience with a congenital platelet abnormality characterized by hyperaggregability with ADP and/or epinephrine. The syndrome has so far been identified in > 200 patients and their families. Clinical symptoms are transient or permanent arterial occlusions, thrombotic in...

  • Inability of Probiotic Bacterial Strains Lactobadilus rhamnosus HN001 and Bifidobacterium lactis HN019 To Induce Human Platelet Aggregation In Vitro. Zhou, J. S.; Rutherfurd, K. J.; Gill, H. S. // Journal of Food Protection;Nov2005, Vol. 68 Issue 11, p2459 

    Platelet aggregation contributes to the pathogenesis of infective endocarditis, and aggregation of platelets induced by lactobacilli is thought to be an important contributory factor in the development and progression of Lactobacillus endocarditis. The main purpose of this study was to examine...

  • Effect Of Intravenous Infusion Of Propofol On Platelet Function During ENT Procedures For Endoscopic Carbon Dioxide Laser, Septoplasty And Endoscopic Nasal Surgery. SAID, KASSIM M // Internet Journal of Otorhinolaryngology;2002, Vol. 1 Issue 1, p15 

    Propofol has inhibitory effect on platelet aggregation by using high dose more than9mg/kg.bw./hour.Also reduce the platelets count during surgery after 30 minutes from start. But has insignificant effect on bleeding time.It was happend in 3%of our cases,using propofol and 10% of cases using more...

  • A new stilbene glycoside from the n-butanol fraction of Veratrum dahuricum. Li-Min Dai; Jian Tang; Hui-Liang Li; Yun-Heng Shen; Cai-Yun Peng; Wei-Dong Zhang // Chemistry of Natural Compounds;May2009, Vol. 45 Issue 3, p325 

    A new stilbene glycoside, 5-methylresveratrol-3,4′- O- β-D-diglucopyranoside ( 1), was isolated from the n-butanol fraction of the rhizomes of Veratrum dahuricum, together with five known stilbenoids: resveratrol-3- O- β-D-glycoside ( 2), 4′-methylresveratrol-3- O-...

  • Modified Technique for Measuring Platelet Aggregation. Kaplan, Alexander; Kaplan, Svetlana; Marcoe, Karen F.; Sauvage, Lester R.; Hammond, William P. // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p196 

    The turbidimetric method of Born is the current approach for assessing the aggregation behavior of platelets. It has been of modest practical value, due to difficulty in standardizing laboratory techniques for plasma preparation and inadequate quantification of the aggregation process. We report...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics